CSN Login
Members Online: 4


Posts: 4
Joined: Dec 2013

Hi all, just a heads up that clinical trials on 3-bromopyruvate(3-BrPa) have begun, & are scheduled to move forward at a significantly fast pace. The company, PreScience Labs, has received fda IND approval to begin human trials, and said trials were scheduled to begin recruiting patients as of Jan 2014.


Hopefully, this will be the beginning of a new age in curing or at least treating breast, lung, pancreatic and ovarian cancers with long term remission as the goal in the not too distant future.

Posts: 1
Joined: Aug 2014

Hi my husband was interested in finding this option do you know where we can find out how to apply for this?

Posts: 2
Joined: Oct 2014

In the last week Cancer Treatment Institute of Colombia (Bogata, Columbia) has flooded the internet with press releases

on PRNewswire announcing their success treating advanced human lung cancer patients with salinomycin and 3-bromopyruvate.

They claim that their treatment has been very effective while causing few, if any, side effects after 21 every other day rounds.


It might be wise to carefully consider this option. The 3-Bromopyruvate research that originated in the United States continues to

inch imperceptibly forward. The initial discovery was made over 10 years ago. The FDA gave clearance to start a phase 1 trial

almost 2 years ago. It is not clear whether this trial will ever start. Travelling to Bogata and dealing with doctors experienced in

3-Bromopyruvate seems very promising.

Posts: 4
Joined: Dec 2013

Well at least there's been some movement in the U.S. wrt this compound, with some seemingly promising results thus far in use for pancreatic cancer




Phase I human clinical trials  set to begin by Jan.-Feb. 2015

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network